Palmarumycin BG-1

Details

Top
Internal ID 51a7ed7f-15cc-4bbd-85c5-bb1057466963
Taxonomy Benzenoids > Tetralins
IUPAC Name (3R)-3,8-dihydroxyspiro[2,3-dihydronaphthalene-4,3'-2,4-dioxatricyclo[7.3.1.05,13]trideca-1(12),5,7,9(13),10-pentaene]-1-one
SMILES (Canonical) C1C(C2(C3=C(C1=O)C(=CC=C3)O)OC4=CC=CC5=C4C(=CC=C5)O2)O
SMILES (Isomeric) C1[C@H](C2(C3=C(C1=O)C(=CC=C3)O)OC4=CC=CC5=C4C(=CC=C5)O2)O
InChI InChI=1S/C20H14O5/c21-13-7-3-6-12-19(13)14(22)10-17(23)20(12)24-15-8-1-4-11-5-2-9-16(25-20)18(11)15/h1-9,17,21,23H,10H2/t17-/m1/s1
InChI Key IDPDCBWKAQHWIS-QGZVFWFLSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C20H14O5
Molecular Weight 334.30 g/mol
Exact Mass 334.08412354 g/mol
Topological Polar Surface Area (TPSA) 76.00 Ų
XlogP 3.40
Atomic LogP (AlogP) 3.12
H-Bond Acceptor 5
H-Bond Donor 2
Rotatable Bonds 0

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of Palmarumycin BG-1

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.8711 87.11%
Caco-2 + 0.5894 58.94%
Blood Brain Barrier - 0.8500 85.00%
Human oral bioavailability - 0.5429 54.29%
Subcellular localzation Mitochondria 0.7024 70.24%
OATP2B1 inhibitior - 0.5848 58.48%
OATP1B1 inhibitior + 0.9256 92.56%
OATP1B3 inhibitior + 0.9317 93.17%
MATE1 inhibitior - 0.9200 92.00%
OCT2 inhibitior - 1.0000 100.00%
BSEP inhibitior - 0.6065 60.65%
P-glycoprotein inhibitior - 0.7620 76.20%
P-glycoprotein substrate - 0.8848 88.48%
CYP3A4 substrate + 0.5283 52.83%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8136 81.36%
CYP3A4 inhibition - 0.8799 87.99%
CYP2C9 inhibition - 0.7351 73.51%
CYP2C19 inhibition - 0.8430 84.30%
CYP2D6 inhibition - 0.8323 83.23%
CYP1A2 inhibition - 0.7800 78.00%
CYP2C8 inhibition - 0.7794 77.94%
CYP inhibitory promiscuity - 0.9388 93.88%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.5409 54.09%
Eye corrosion - 0.9886 98.86%
Eye irritation + 0.6116 61.16%
Skin irritation - 0.5342 53.42%
Skin corrosion - 0.9561 95.61%
Ames mutagenesis + 0.7200 72.00%
Human Ether-a-go-go-Related Gene inhibition - 0.7689 76.89%
Micronuclear + 0.8059 80.59%
Hepatotoxicity + 0.5033 50.33%
skin sensitisation - 0.7863 78.63%
Respiratory toxicity + 0.7222 72.22%
Reproductive toxicity + 0.8111 81.11%
Mitochondrial toxicity + 0.7375 73.75%
Nephrotoxicity + 0.8517 85.17%
Acute Oral Toxicity (c) III 0.3762 37.62%
Estrogen receptor binding + 0.7732 77.32%
Androgen receptor binding + 0.6527 65.27%
Thyroid receptor binding - 0.5226 52.26%
Glucocorticoid receptor binding - 0.5463 54.63%
Aromatase binding + 0.5835 58.35%
PPAR gamma + 0.8647 86.47%
Honey bee toxicity - 0.8720 87.20%
Biodegradation - 0.7750 77.50%
Crustacea aquatic toxicity + 0.5400 54.00%
Fish aquatic toxicity + 0.7058 70.58%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.24% 91.11%
CHEMBL2581 P07339 Cathepsin D 92.99% 98.95%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 92.66% 99.23%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 91.25% 95.56%
CHEMBL3137262 O60341 LSD1/CoREST complex 89.95% 97.09%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 89.04% 94.45%
CHEMBL2553 Q15418 Ribosomal protein S6 kinase alpha 1 87.95% 85.11%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 86.35% 94.00%
CHEMBL240 Q12809 HERG 84.90% 89.76%
CHEMBL1951 P21397 Monoamine oxidase A 84.36% 91.49%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 82.52% 96.09%
CHEMBL1806 P11388 DNA topoisomerase II alpha 82.12% 89.00%
CHEMBL1860 P10827 Thyroid hormone receptor alpha 81.50% 99.15%
CHEMBL1937 Q92769 Histone deacetylase 2 80.69% 94.75%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 80.63% 90.71%

Cross-Links

Top
PubChem 51354122
NPASS NPC260691